According to GenSight Biologics's latest financial reports the company's current earnings are S$1.4 Million. In 2023 the company made an earning of -S$38.05 Million, an increase over its 2022 earnings that were of -S$38.89 Million. The earnings displayed on this page is the company's Pretax Income.